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Mitochondrial dynamicsembrane enclosed eukaryotic organelles with a central role in numerous cellular
functions. The ultrastructure of mitochondria varies considerably between tissues, organisms, and the
physiological state of cells. Alterations and remodeling of inner membrane structures are evident in
numerous human disorders and during apoptosis. The inner membrane is composed of two subcompart-
ments, the cristae membrane and the inner boundary membrane. Recent advances in electron tomography
led to the current view that these membrane domains are connected by rather small tubular structures,
termed crista junctions. They have been proposed to regulate the dynamic distribution of proteins and lipids
as well as of soluble metabolites between individual mitochondrial subcompartments. One example is the
release of cytochrome c upon induction of apoptosis. However, only little is known on the molecular
mechanisms mediating the formation and maintenance of cristae and crista junctions. Here we review the
current knowledge of the factors that determine cristae morphology and how the latter is linked to
mitochondrial function. Further, we formulate several theoretical models which could account for the de
novo formation of cristae as well as their propagation from existing cristae.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionMitochondrial research has inﬂuenced numerous scientiﬁc dis-
ciplines over the last 150 years [1,2]. These organelles have been
morphologically described as threads (German, ‘Faden’; Greek ‘mitos’)
or grains (German, ‘Körper’; Greek ‘chondros’) in various tissues as
early as in the 1850s leading to the name ‘Fadenkörper’ (German) or
‘mitochondria’ (Greek). Initially, mitochondrial research was focused
on a number of fundamental metabolic and bioenergetic functions,
such as oxidative phosphorylation (OXPHOS), Krebs cycle, heme
biosynthesis, β-oxidation of fatty acids, and the metabolism of certain
amino acids [2]. The discovery of mitochondrial DNA in the 1960s
fueled the scientiﬁc discussion about the evolution of mitochondria by
endosymbiosis [3]. More recently, targeting and import of proteins
into mitochondria [4], biogenesis of Fe/S clusters [5], and the role of
mitochondria in controlling apoptosis in higher eukaryotes [6]
have substantially extended the interest in mitochondrial research.
In light of the fundamental roles of mitochondria it is not unexpected
that dysfunction of this organelle is linked to a wide range of human
diseases, including numerous neuropathies and myopathies [7].
Furthermore, the accumulation of mutations in mitochondrial DNA
was shown to result in premature ageing of mice [8] providing
compelling evidence that mitochondrial dysfunction not only pre-
cedes but also has to be considered as a causative factor in aging of
mammals.: +49 69 6301 87162.
l rights reserved.Mitochondria are surrounded by two membranes: the outer
membrane (OM) and the inner membrane (IM). Within the inner
membrane two distinct regions can be distinguished: the inner
boundary membrane (IBM) and the cristae membrane (CM). The IBM
is adjacent to the outer membrane whereas the CM represents
invaginations of the IBM that protrude into thematrix space. This view
of a double-membrane enclosed organelle with inner membrane
convolutions was established with the pioneering work in electron
microscopy of Palade and Sjöstrand in the 1950s [9]. It quickly became
clear that mitochondria exhibit an extremely large variability of
ultrastructures depending on the tissue, the physiological state, and
the developmental stage [10,11]. Tubular, lamellar and even triangle-
shaped cristae membranes (Fig. 1) have been observed [10–12].
Alterations of mitochondrial structures, often accompanied by inclu-
sions or aggregates in the mitochondrial matrix, are well known for
numerous diseases in humans. For example, in lymphoblasts of
patients suffering from Barth syndrome mitochondria appear
enlarged with grossly reduced inner membrane surface area [13].
They mostly exhibit a few but deranged cristae, while also several
giant mitochondria with a completely disorganized inner membrane
topology, in particular concentric stacks of inner membrane or
honeycomb conﬁgurations, have been observed. Barth syndrome is a
mitochondrial disorder caused by mutations in tafazzin [14], which is
involved in the biosynthesis of mitochondrial phospholipids such as
cardiolipin [15]. This indicates that certain phospholipids are crucial
for maintaining mitochondrial ultrastructure. Also in Alzheimer's
disease mitochondrial morphology is altered in such a way that
cristae are disrupted, and inclusions within mitochondria and varying
Fig. 1. Diversity of mitochondrial ultrastructures. Different types of cristae are shown from various tissues under normal (A–D) or pathogenic conditions (E, F): (A) Adrenal cortex. (B)
Astrocyte. (C) Fish pseudobranch. (D) Ventricular cardiac muscle (A–D taken from [10]). (E and F). Chronic polymyositis with Raynaud's syndrome (taken from [30]).
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parallel stacks of cristae membranes were observed [16]. Inclusions
and altered cristae morphology were also found in the skeletal muscle
of patients with amyotrophic lateral sclerosis [17]. Several other
examples of human diseases with alterations of mitochondrial
morphology have been reported (see Table 1), such as Parkinson's
disease [18–22], Wolf–Hirschhorn syndrome [23–25], Wilson disease
[26–28], 3-methylglutaconic aciduria [29], chronic polymyositis [30],
and hereditary mitochondrial hypertrophic cardiomyopathy [31].
Here, we aim to review our current understanding on how
mitochondrial function and structure are linked to each other and,
particularly, what molecular mechanisms are known to mediate
cristae formation.2. Mitochondrial architecture — changing views
The use of electronmicroscopy in the 1950s boostedmitochondrial
research considerably as it allowed novel insights into the internal
structure of mitochondria. However, determining and interpreting
ultrastructural details of mitochondria is a challenging task. On the
one hand it is desirable to obtain high resolution of structural details.
On the other hand mitochondria are rather large, elongated tubular
structures within the cytosol covering the length of up to several
hundred µm making the simultaneous analysis of larger volumes
difﬁcult. For the elucidation of small membrane structures the use of
electron microscopy is the method of choice. However, sections used
for electron microscopy have a certain thickness of at least 5 but
Table 1
Candidate proteins determining cristae morphology
Protein (organism) Aberration of mitochondrial
ultrastructure
Assigned function Associated human disorder References
Atp21p/Tim11p (su e),
Atp20p (su g), Atp4p
(S. cerevisiae)
Onion-like, elongated cristae Dimerization and higher order
oligomerization components of the
F1FO-ATP synthase
– [4,84,85,87–89]
ATP6/Atp6p (H. sapiens,
D. melanogaster,
S. cerevisiae)
Aberrant mitochondrial morphology;
IM vesicles, septa
Proton channel of F1FO-ATP synthase Neuropathy, ataxia and
retinitis pigmentosa (NARP),
maternally inherited Leigh
syndrome (MILS)
[95,98,100]
PINK1 (H. sapiens, C. elegans,
D. melanogaster)
Swollen mitochondria; cristae
fragmentation
Mitochondrial serine/threonine kinase "; Parkinson's disease [18,174,178]
Tafazzin (H. sapiens) Fragmentation of mitochondria;
reduced cristae surface
Acyltransferase involved in the
biosynthesis of mitochondrial
phospholipids
Barth syndrome (BTHS) [13,73]
DICE1/DIC-1 (H. sapiens,
C. elegans)
Aberrant IM ultrastructure,
IM vesiculation
Tumor suppressor protein Various types of cancer
(e.g. lung carcinoma,
prostate cancer)
[18, 153–155]
AIF (M. musculus) Aberrant IM topology Induction of apoptosis – [152]
Mdm33p (S. cerevisiae) Aberrant mitochondria; overexpression
leads to loss of cristae
Fission of inner mitochondrial membrane – [163]
Mmm1p (S. cerevisiae) Spherical mitochondria; disorganization
of IM
Maintenance of mtDNA; import and
assembly of beta-barrel proteins
– [164,165,169]
LETM1/Mdm38p (H. sapiens,
D. melanogaster, C. elegans;
S. cerevisiae)
Osmotic swelling; loss of membrane
potential; mitochondrial fragmentation
K+/H+ exchange; chaperone for
mitochondrial IM proteins
Wolf–Hirschhorn syndrome [24,170,171]
OPA1/Mgm1p (H. sapiens;
M. musculus; S. cerevisiae)
Cristae remodeling during apoptosis;
reduction in observable normal cristae;
accumulation of septa
Remodeling of CJs; inner membrane fusion;
cristae maintenance
Autosomal dominant optic
atrophy (ADOA)
[119,123, 124, 126]
Prohibitins (PHB1/Phb1p,
PHB2/Phb2p) (H. sapiens;
M. musculus; S. cerevisiae)
Loss of cristae and vesiculation of the IM Various cellular functions; mtDNA
maintenance; regulation of mitochondrial
protein turnover; regulation of OPA1
processing, membrane bound chaperon
Various forms of cancer [129,183, 204–206]
Mitoﬁlin (H. sapiens) Absence of CJs; disorganization
of the IM; increased IM:OM ratio
Organization of cristae and CJs Down syndrome [184,188]
Abrogating the function of these proteins leads to aberrations of mitochondrial ultrastructure. Thus, they are presumed to be directly or indirectly involved in cristae formation. Some
of these proteins have been linked to a human disorder (see text). Proteinswith a causative role in human disease are highlighted in bold. OM, outer membrane; IM, innermembrane;
CJs, crista junctions.
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used for the reconstruction of a mitochondrial volume a low
resolution along the z-axis and distortion of the obtained reconstruc-
tions along this dimension remains. This severely limits the conclu-
sions that can be drawn from the analysis of serial sections of
mitochondria and may explain the controversial discussion concern-
ing the arrangement of inner membrane structures in mitochondria in
the last decades. Several hypothetical models have been proposed
(Fig. 2), among them the one of Palade which conﬁrmed the existence
of an outer and an inner membrane and suggested the inner
membrane to be folded into “cristae mitochondriales” [32,33]. In
this ‘bafﬂe model’ cristae are regarded as invaginations of the inner
membrane with rather broad openings (Fig. 2A). Another interpreta-
tion of the appearance of inner membrane structures as observed in
sections of electron micrographs was proposed by Sjöstrand as the
‘septa model’ [34,35]. Thereby, the surface of the inner membrane is
increased due to the formation of septa (Fig. 2B). Opposing views to
these models existed already more than 50 years ago [36–38]. With
the analysis of very thin serial sections of mitochondria by transmis-
sion electron microscopy Daems and Wisse (1966) identiﬁed small
tubular structures connecting cristae with the IBM which they named
pediculi cristae (“crista feet”). Although this view did not achieve
acceptance and rather the ‘bafﬂe model’ entered most textbooks it
recently obtained strong support when Mannella and colleagues
applied electron tomography (EM tomography) to determine the
mitochondrial ultrastructure of isolated rat livermitochondria [39,40].
EM tomography allows the three-dimensional reconstruction of
volumes of rather thick sections (∼0.5 µm). For this a series of
electron micrographs is recorded while the sample is tilted over a
wide range of angles. By computational analysis the three-dimen-
sional structure of the entire specimen can be reconstructed at a highresolution. Several studies revealed that cristae are attached to the
IBM by narrow, tubular openings which were termed “crista
junctions” (CJs) [39–43]. CJs are present in mitochondria of various
tissues and organisms, such as neurons from chicken, rat, and mouse
[44,45], brown adipocytes [46], human lymphoblasts [13], Neurospora
crassa [47,48], and Saccharomyces cerevisiae (Fig. 3). Although a wide
spectrum of cristae appearances has been described, CJs rather appear
to exhibit uniform sizes and shapes. The narrow tubular, ring- or slot-
like structures exhibit diameters ranging from 12 to 40 nm [41,45,47].
While most CJs measure 30 to 50 nm in length, also longer specimens
measuring 150–200 nm have been observed in N. crassa [47].
Condensation of the matrix space of a mitochondrion (“condensed
state”) results in the appearance of CJs in comparison to a
mitochondrion subjected to osmotic swelling of the matrix space
(“orthodox state”). As this appears to be reversible a dynamic
formation of CJs was proposed [42]. Inhibiting mitochondrial protein
import in N. crassa led to a simultaneous reduction of cristae
membranes and CJs [48]. Remnants of CJs, however, were not
observed indicating that CJs are not permanent structures. Although
more and more structural details on CJs become available it is still
open what the functional signiﬁcance of these structures is.
3. Subcompartmentalization of the inner mitochondrial
membrane
One idea was that CJs play a crucial role in establishing inner-
mitochondrial subcompartments [40]. They could represent diffusion
barriers between the intermembrane space (IMS) and the intracristal
space (ICS) as well as between the IBM and the CM. A possible
consequence would be to prevent or limit diffusion of metabolites
such as protons and ADP [43,44]. This would indeed be of gross impact
Fig. 2. Models of mitochondrial inner membrane topology. With the discovery of the
dual membrane nature of mitochondria the pioneers of mitochondrial ultrastructural
research proposed different models for the organization of the mitochondrial inner
membrane. (A) ‘Bafﬂe model’. According to Palade [32,33] the mitochondrial inner
membrane is convoluted in a bafﬂe-like manner with broad openings towards the
intracristal space. This model entered most textbooks and was widely believed for a
long time. (B) ‘Septa model’. Sjöstrand suggested that sheets of inner membrane are
spanned like septa trough the matrix separating it into several distinct compartments
[34]. (C) ‘Crista junction model’. Daems and Wisse [38] proposed that cristae are
connected to the inner boundary membrane via tubular structures characterized by
rather small diameters. These structures, termed crista junctions (CJs), were
rediscovered recently by EM tomography leading to the establishment of this currently
widely accepted model [39,40].
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metabolite is ADP. Thus, the shape and size of CJs could contribute to
the regulation of the rates of ATP production by limiting ADP ﬂux
[39,41]. Moreover, the diffusion of large protein complexes within the
lipid bilayer of the inner membrane could be regulated by CJs. In
particular, oligomeric complexes might be prone to be trapped in one
or the other subcompartment [44,49,50]. The idea of distinct
subcompartments within the mitochondrial inner membrane is not
new and has been discussed since IBM and CM could be distinguished
morphologically by electron microscopy. The biochemical fractiona-
tion of submitochondrial membrane vesicles allowed the ﬁrstFig. 3. Cryo-EM tomogram of a crista junction in Saccharomyces cerevisiae. (A) Single slice thr
Magniﬁed view of boxed area in left panel. (C) Surface rendered view of a crista junction. Scharacterizations of these subcompartments together withmembrane
domains, termed contact sites, in which the outer membrane closely
apposes the IBM [51–54]. However, these approaches require the
isolation and rupture of mitochondria making it difﬁcult to exclude
any artiﬁcial redistribution of protein complexes during analysis [55].
Still, these studies and the localization of certain marker proteins in
isolated mitochondria by using electron microscopy suggested the CM
to be the preferential site of oxidative phosphorylation [56,57].
Furthermore, two recent studies using whole cells and a larger set
of marker proteins provided strong support that the inner membrane
is indeed composed of two subcompartments [50,58]. By using
mutants with enlarged mitochondria Wurm and Jakobs were able to
determine the submitochondrial location of a number of proteins in
baker's yeast using ﬂuorescence microscopy [58]. Components
involved in oxidative phosphorylation clearly stained the interior
and thus the CM of mitochondria, whereas proteins involved in
protein translocation stained the periphery and thus the IBM of
mitochondria. A systematic approach using quantitative immunoelec-
tron microscopy in intact wild type yeast cells also revealed an
uneven, yet not exclusive, distribution of proteins in the inner
mitochondrial membrane [50]. In total 20 inner membrane proteins
representing seven major processes (oxidative phosphorylation,
protein translocation, metabolite exchange, mitochondrial morphol-
ogy, protein translation, iron/sulfur cluster biogenesis, and protein
degradation) were analyzed (Fig. 4). The CM was enriched in proteins
involved in oxidative phosphorylation, iron/sulfur cluster biogenesis,
protein synthesis and transport of mtDNA-encoded proteins, whereas
the IBMwas enriched in proteins involved inmitochondrial fusion and
protein transport of nuclear-encoded proteins. Furthermore, a
dynamic redistribution of these proteins between the two compart-
ments of the inner membrane was shown to occur upon changes in
the physiological state [50]. Under steady-state conditions Tim23p, an
essential component for mitochondrial protein import, is preferen-
tially found in the IBM. This enrichment is slightly increased when
import is stimulated upon overexpression of a mitochondrial protein
and, conversely, Tim23p redistributes partially to the CMwhen import
is arrested due to inhibition of cytosolic protein synthesis. Apparently,
Tim23p can dynamically relocate within the innermembrane opening
the possibility that the CM may also act as a kind of reservoir for
protein complexes functioning in the IBM.
Another example for the dynamics of large protein complexes in
the inner membrane was obtained from analyzing a yeast mutant
(Δbcs1) defective in the assembly of complex III and of the super-
complex of complex III and IV. While in wild type the fully assembled
complex III is mostly present in the CM, in the Δbcs1mutant the non-
assembled Fe/S-Rieske protein subunit of complex III partially
redistributes to the IBM [50]. It is interesting to note that this subunit
is also nuclear-encoded and thus preferentially imported at the IBM,ough a tomogram of an isolated vitriﬁed wild type mitochondrion from S. cerevisiae. (B)
cale bars 100 nm. EM tomogram with courtesy of Dr Marek Cyrklaff.
Fig. 4. Subcompartmentalization of the mitochondrial inner membrane. The distribution of mitochondrial proteins involved in several major processes of mitochondria has been
determined by quantitative immunoelectron microscopy in S. cerevisiae [50]. Inner membrane proteins involved in mitochondrial fusion (Mgm1p) or protein translocation (Mia40p,
TIM23 complex) are preferentially located in the inner boundary membrane. In contrast, proteins involved in oxidative phosphorylation (ANC, Complex III, Complex IV, F1FO-ATP
synthase) and in iron/sulfur cluster biogenesis (Fe/S cluster) are enriched in the cristae membrane. This distribution is uneven, yet not exclusive nor static. Proteins dynamically
redistribute between the domains depending on the physiological state of the cell. CS, Cytosol; OM, outer membrane; IMS, intermembrane space; IM, inner membrane; M, matrix
space. Style adapted from the illustrations of Graham T. Johson in [203].
9M. Zick et al. / Biochimica et Biophysica Acta 1793 (2009) 5–19whereas Cox2p is mtDNA-encoded and might, based on the afore-
mentioned results, be preferentially imported and inserted in the CM.
This subunit of complex IV is more enriched in the CM in the Δbcs1
mutant as compared to the wild type. Although these observations do
not allow any conclusion concerning the question in which sub-
compartment the supercomplex III2IV2 actually assembles, it still
points to the possibility that a coordinated insertion of protein
subunits in distinct locations of the inner membrane is important for
proper assembly and localization of respiratory chain complexes.
Taken together, the observed protein distributions are dynamic and
correlate with the known function of the analyzed components. This
dynamic behavior at the inner mitochondrial level extends our
concept of CJs which might not function as strict diffusion barriers
to membrane proteins as previously assumed. Unraveling the under-
lying molecular mechanisms leading to distinct subcompartments of
the mitochondrial inner membrane, but still allowing a dynamic
reorganization between these domains, will be one important future
challenge in mitochondrial research.
4. Cristae morphology from a bioenergetic point of view
One of the main functions of mitochondria is the use of dietary
calories to synthesize ATP. By the action of the respiratory chain an
electrochemical gradient across the inner mitochondrial membrane is
establishedwhich serves as the driving force for the production of ATP
from ADP and inorganic phosphate by the mitochondrial F1FO-ATP
synthase. Already in the 1950s, after the ﬁrst visualizations of
mitochondrial ultrastructures by electron microscopy, convolutionsof the mitochondrial inner membrane were proposed to lead to an
increase in membrane surface and thus to enhance the capacity of
oxidative phosphorylation [32]. This is in line with the, compared to
other biological membranes, extremely high ratio of protein to lipid
mass (∼75:25) of the mitochondrial inner membrane [1]. The largest
proportion of these proteins is involved in oxidative phosphorylation
and the surface area of cristae positively correlates with the amount of
ATP produced by oxidative phosphorylation in various tissues. The
mitochondrial CM further was hypothesized to serve as a specialized
compartment ensuring optimal conditions for ATP production [32].
How could cristae formation be accomplished on a molecular level
and what could be the beneﬁt of this process that goes beyond a mere
surface increase? Based on a mathematical model Demongeot et al.
recently suggested as one function of mitochondrial cristae their
capacity to minimize the mean distance between adenine nucleotide
translocation and transformation sites for highest efﬁciency of ATP
production [59]. In addition, long before Mitchell formulated the
chemiosmotic theory of oxidative phosphorylation [60], the arrange-
ment of the respiratory chain within the inner membrane was
proposed to be dependent “on a deﬁnite, spatial arrangement of its
individual components and thus on the structural integrity of the
mitochondrion” [61]. In the meantime, complexes of the respiratory
chain have been shown to form large supermolecular assemblies,
termed respiratory supercomplexes or ‘respirasomes’, [62–67]. This
type of organization was hypothesized to be of high functional
importance for optimizing electron transport during respiration
[66,68,69]. However, whether respiratory chain supercomplexes also
participate in determining the structure of cristae is an open question.
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mitochondrial membranes, has also been implicated in contributing to
the characteristic shape of the mitochondrial inner membrane.
Mitochondria of patients suffering from Barth syndrome exhibit an
80% reduction in cardiolipin content which is accompanied by severe
ultrastructural changes of the mitochondrial inner membrane
topology [13,70–72]. Cardiolipin has been reported to stabilize
supercomplexes of the respiratory chain as revealed by blue native
gel electrophoresis of detergent-solubilized mitochondria [73–75].
Thus, it remains to be elucidated whether cardiolipin exerts a direct
inﬂuence on the inner membrane curvature or rather affects inner
membrane topology via stabilizing higher order enzymatic com-
plexes. In the 1970s, structural changes in mitochondria have also
been ascribed to the inhibition of the adenine nucleotide carrier (ANC)
by Klingenberg and colleagues [76]. This was hypothesized to be
caused by redistribution or conformational changes of ANC upon
inhibition [76,77]. However, later Klingenberg himself questioned
whether the carrier protein alone could explain the observed mor-
phological changes [78].
Hackenbrock was the ﬁrst to show that the topology of the
mitochondrial inner membrane is subjected to extensive morpholo-
gical changes depending on the respiratory state of mitochondria
[79,80]. In respiratory state III, which is characterized by an excess of
ADP, isolated rat liver mitochondria showed a condensed conforma-
tion with large swollen intra-cristal space volume, while under ADP
limiting conditions (respiratory state IV) this volumewas considerably
smaller, characteristic for the orthodox conformation. Based on
simulations, Mannella and colleagues speculated that this dynamic
morphological shift could optimize diffusion of metabolites [42]. In
summary, mitochondrial ultrastructure is clearly linked to the
bioenergetic state of mitochondria. However, so far little is known
about the key factors that actually determine cristae structure, howFig. 5. Role of the dimerization and oligomerization of the F1FO-ATP synthase in cristae forma
synthase (with courtesy of Dr Frank Vogel). Cristae exhibit typical onion-like inner membran
synthase is strongly impaired. (B) Model for the induction of membrane curvature by dime
yeast with its monomers tilted by 35° [102] is depicted in side view (adapted from the illus
several organisms; however the tilt angle between monomers varies considerably. (C) Putati
Subunits e and g may stabilize dimers by forming one interaction interface, and subunit 4 c
order oligomeric complexes. However, the role of other subunits in the formation or s
intermembrane space; IM, inner membrane; M, matrix.certain ultrastructures facilitate fundamental mitochondrial func-
tions, or whether cristae are dynamic structures.
5. Role of the F1FO-ATP synthase in cristae formation
Since a few years there is strong evidence that the mitochondrial
F1FO-ATP synthase, apart from its enzymatic activity, plays a major
role in determining the structure of cristae. In Paramecium multi-
micronucleatum a regular, zipper-like association of F1FO-ATP synthase
dimers surrounding tubular cristae was observed [81]. The association
of F1FO-ATP synthase dimers into higher order oligomers was
proposed to be responsible for the tubulation of the mitochondrial
inner membrane [82]. The regular arrangement of this highly
abundant protein complex might serve as a kind of backbone
stabilizing tubular cristae structures. Subunits e (Atp21p/Tim11p)
and g (Atp20p) are components of the mitochondrial F1FO-ATP
synthase which are neither essential for ATP synthesis nor hydrolysis,
but crucial for the dimerization and higher order oligomerization of
the F1FO-ATP synthase [83]. It was reported that yeast cells either
lacking subunits e or g contain cristae membranes which are arranged
in concentric circles resembling an onion-like structure [84–86] (Fig.
5A). Downregulation of these subunits revealed similar results [87].
Also mutant variants of subunit 4, orthologous to the b-subunit in
mammals, lead to a destabilization of the F1FO-ATP synthase dimers/
oligomers and to onion-like cristae structures in yeast [88,89]. In vivo
cross-linking of F1FO-ATP synthases via their F1-portions resulted in a
similar ultrastructural phenotype [90] further emphasizing the crucial
role of the oligomerization of this protein complex in determining
normal inner membrane topology.
Currently the nature and importance of possible interfaces
mediating dimerization and oligomerization of this complex are
hotly debated. Paumard and colleagues proposed a model for thetion. (A) Electronmicrograph of a yeast mitochondrion lacking subunit e of the F1FO-ATP
e sheets in this mutant in which also dimerization and oligomerization of the F1FO-ATP
rs of the F1FO-ATP synthase. A dimer of the mitochondrial F1FO-ATP synthase of baker's
trations of Graham T. Johson in [203]). Dimers of this complex have been observed for
ve arrangement of F1FO-ATP synthase oligomers shown as top view (adapted from [85]).
ould be involved in forming another interface to interconnect these dimers into higher
tabilization of F1FO-ATP synthase dimers and oligomers is currently debated. IMS,
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interfaces are responsible for the association of F1FO-ATP synthase
monomers through their FO-portions. The ﬁrst one is composed of
subunits e and g, the second one involves subunit 4 (subunit b) (Fig.
5C). The roles of subunits e and g in dimer formation in vivo were
challenged as also in the absence of subunits e or g a physical
neighborhood between monomers of the F1FO-ATP synthase could be
observed using FRET (ﬂuorescence resonance energy transfer) [91] or
cross-linking approaches [92]. However, this still would be consistent
with the perpetuation of an alternative interface such as the one
exerted by subunit 4. Also downregulation of subunit h resulted in a
loss of F1FO-ATP synthase dimers/oligomers accompanied by clear
topological changes of themitochondrial innermembrane [93].Wittig
et al. recently proposed that subunit 6 (a) forms stable dimers and
mediates the interaction between two subunit 910-rings (c10) of the
F1FO-ATP synthase which is further stabilized through subunits e.g., 4,
i, and h [94]. Using clear native polyacrylamide gel electrophoresis
(CN-PAGE) the same authors provided ﬁrst evidence that indeed the
dimers of the F1FO-ATP synthase are the building blocks of oligomers,
as most oligomeric forms contain an even number of monomers [94].
A recent study by Celotto et al. has revealed ultrastructural defects of
the mitochondrial inner membrane in Drosophila cells harboring a
mutation in the mitochondrial ATP6 gene [95]. This subunit is an
essential component of the mitochondrial F1FO-ATP synthase that
functions as a proton channel coupling the proton motive force to ATP
synthesis [96,97]. Point mutations within the ATP6 gene are linked to
several encephalomyopathies like NARP (neuropathy ataxia and
retinitis pigmentosa) or MILS (maternally inherited Leigh syndrome)
[98]. The Drosophila ATP6mutant shows a high percentage of aberrant
mitochondria with a honeycomb appearance [95]. Detailed tomo-
graphic analysis revealed numerous inner membrane vesicles which
are often interconnected with each other and with the IBM. The cause
of the perturbation of the mitochondrial inner membrane in this
mutant has still to be examined. Surprisingly, in yeast a pointmutation
of the ATP6 gene resembling the NARP T8993G mutation does not
show an effect on mitochondrial ultrastructure [99] and even in the
Δatp6 deletion strain cristae structures were observed [100], indicat-
ing that the subunit 6 of the F1FO-ATP synthase is not absolutely
required for the formation of cristae. Interestingly, the inner
membrane often showed septa-like structures, but those electron
micrographs presented to underline this claim lacked any discernible
cristae. Thus, cristae formation might in principle be possible but still
appears impaired in cells lacking ATP6 consistent with aforemen-
tioned results from other organisms. In addition, profound morpho-
logical alterations of the mitochondrial network were observed in the
Δatp6 deletion strain, which, in conjunction with the septa-like
structures, was attributed to a delayed inner membrane fusion due to
the bioenergetic impairment [100]. The latter is consistent with earlier
reports showing that [Float1]in a different ATP6mutant the formation
of the short isoform of Mgm1p is compromised resulting in impaired
fusion of mitochondria [101]. Taken together, although the importance
of the F1FO-ATP synthase in cristae formation is apparent, future
studies are required in order to decipher the molecular determinants
for the assembly of higher oligomeric forms of this complex.
In this regard the determination of the three-dimensional
structure of the higher oligomeric assemblies of the F1FO-ATP
synthase is certainly highly desirable and considerable progress has
been made recently. Analysis by single particle electron microscopic
studies revealed two different types of F1FO-ATP synthase dimers in
yeast which are oriented with an angle of 35° or 90° between the long
axes of the F1FO-ATP synthase monomers [102]. For bovine heart [103]
and the colorless alga Polytomella [104] angles of about 40° and 70°,
respectively, have been obtained. Whether the observed variation
between these species is due to their distant evolutionary relation or
whether it is derived from different classes of dimers, wide-angle
dimers (70°–90°) and small-angle dimers (35°–40°), remains an openquestion [102]. Dudkina et al. propose that the two conformations of
F1FO-ATP synthase dimers could result from different breakdown
products of F1FO-ATP synthase oligomers that interact via different
domains [102].
Rows of F1FO-ATP synthase dimers were recently observed in
membrane fractions from yeast mitochondria using atomic force
microscopy [105]. These rows were similar to the ones described in P.
multimicronucleatum with rapid-freeze deep-etch electron micro-
scopy [81] (Fig. 5C). Buzhynskyy et al. observed two classes of F1FO-
ATP synthase dimers and propose that one class represents active
F1FO-ATP synthase dimers, while the other one is inactive [105].
Several reports discuss the possibility that dimerization and oligo-
merization of this complex inﬂicts a certain membrane curvature to
the CM [102,103,106] (Fig. 5B). Recently, it has been speculated that
such a spatial arrangement results in a membrane curvature that
locally increases the pH gradient and in this way the F1FO-ATP
synthase would optimize its own performance by shaping cristae as
proton traps [106]. Furthermore, Bornhövd et al. have shown that the
stability of F1FO-ATP synthase oligomers affects the mitochondrial
membrane potential ΔΨ, and have put forward the hypothesis that
F1FO-ATP synthase supercomplexesmay play a role in the organization
of microdomains of OXPHOS complexes within the inner mitochon-
drial membrane [86]. Still, further studies are needed to answer which
advantage a higher order oligomerization of the F1FO-ATP synthase
actually provides to the bioenergetic function of mitochondria.
6. Cristae remodeling in apoptosis
In addition to their key role in energy metabolism, mitochondria
take a central position in the regulation of programmed cell death.
They integrate numerous apoptotic stimuli and play a pivotal role in
the initiation of apoptosis. A central step in the mitochondrial
apoptotic pathway is the release of soluble apoptogenic proteins
upon selective permeabilization of the outer mitochondrial mem-
brane [107,108]. Mitochondria are involved in caspase-dependent
(cytochrome c, Smac/Diablo, Omi/HtrA2) as well as caspase-indepen-
dent (AIF, endonuclease G) death pathways [109–112]. Upon apoptotic
stimuli a major caspase-activating pathway is triggered by cyto-
chrome c [6,113,114]. The release of cytochrome c upon permeabiliza-
tion of the outer membrane was observed to be complete [115,116],
although more than an estimated 85% of cytochrome c is stored in the
intracristal space [117]. Scorrano and colleagues have shown that after
induction of apoptosis an extensive remodeling of the mitochondrial
inner membrane occurs resulting in an increased accessibility of
cytochrome c [118]. These results led to the hypothesis that
remodeling of the CM, particularly of CJs, is a necessary step in
apoptosis [118]. What are the molecular mechanisms that could
explain cristae remodeling and the release of cytochrome c?
7. The role of OPA1 in apoptotic cristae remodeling
One key player turned out to be OPA1, a large dynamin-like GTPase,
which is associated withmutations causing autosomal dominant optic
atrophy type I [119,120]. OPA1 is known to be required for
mitochondrial fusion [121,122]. Further, downregulation of OPA1 by
RNAi resulted in ultrastructural changes of cristae and accelerated
release of cytochrome c upon induction of apoptosis [121]. The role of
OPA1 in a cristae-remodeling pathway received further support as
OPA1 overexpressionwas anti-apoptotic and induced tightening of CJs
[123,124]. The latter was attributed to the capacity of OPA1 to engage
in homotypic interactions. Disruption of an OPA1 complex might
therefore explain the increased sensitivity for cristae remodeling and
release of cytochrome c upon induction of apoptosis [123–125]. Also
Mgm1p, the yeast ortholog of OPA1, was proposed to make homotypic
interactions and to be required for formation of normal amounts of
cristae structures [126]. The activity of OPA1 in mitochondrial fusion
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[127,128]. This process causes changes of mitochondrial morphology
in several model systems of mitochondrial dysfunction and could
allow the spatial separation and removal of damaged mitochondria by
autophagy [127]. Recently, processing of large OPA1 isoforms was
shown to exert an essential function in cristae morphogenesis in a
process controlled by prohibitins [129]. PHB2-deﬁcient cells exhibit a
selective loss of larger OPA1 isoforms. This goes along with an
aberrant inner membrane topology and increased sensitivity towards
apoptotic stimuli, defects that can be suppressed by overexpression of
larger OPA1 isoforms. Several mitochondrial proteases have been
discussed to be responsible for OPA1 cleavage at different sites,
including PARL [123,125], the i-AAA protease Yme1L [130,131], and the
m-AAA protease [128,132]. As prohibitins are known to regulate
protein degradation by m-AAA proteases in yeast [133] the role of the
m-AAA protease appears to be of particular importance in this process.
Future studies, however, are needed to clarify the regulation of cristae
formation by one or more of these proteases.
8. Other candidates involved in cristae remodeling during
apoptosis
The Bcl-2 protein family is a large group of proteins involved in the
regulation of programmed cell death by performing either pro- or
anti-apoptotic activity [134]. Administration of tBid, a truncated form
of the pro-apoptotic BH3-only protein Bid [135], to isolated mouse
liver mitochondria induced considerable remodeling of the mitochon-
drial inner membrane and liberation of cytochrome c into the in-
termembrane space [118]. While the mechanism behind this
phenomenon is yet not quite clear, an interaction of tBid with
cardiolipin preferentially at mitochondrial contact sites has been
implicated in the observed cristae reorganization [136,137].
The interplay between mitochondria and the endoplasmatic
reticulum (ER) could also play an important role in the regulation of
apoptosis as well [138–140]. BIK, a BH3-only protein located in the ER,
activates transmission of Ca2+ from the ER to mitochondria, which
results in the recruitment of DRP1 to mitochondria and thereby
appears to contribute to cristae remodeling [141] (extensively re-
viewed in [142]). In agreement with this, Zhang et al. have reported an
involvement of mitochondrial permeability transition in the remodel-
ing of CJs, and thus cytochrome c release, during ER stress [143]. The
precise mode of action underlying these processes, however, still
needs to be determined.
The apoptosis-inducing factor (AIF) exhibits a dual function in
cellular life and death (reviewed in [144–146]). On the one hand it
may act as the main mediator of caspase-independent apoptosis-like
programmed cell death [147–149] while on the other hand it may
exert vital functions within mitochondria, like sustaining oxidative
phosphorylation by governing the integrity of the respiratory chain
complexes (mainly complex I) [150] and scavenging of reactive oxygen
species [151]. In order to distinguish between these two opposing
functions, Cheung et al. have constructed and analyzed a mitochon-
drial inner membrane anchored form of AIF [152]. Interestingly, they
found AIF to be required for the maintenance of normal cristae
structure. Knockout of AIF led to the formation of aberrant, dilated
cristae, while the expression of anchored AIF could restore wild type
like cristae morphology [152]. Thus, AIF may have two distinct pro-
apoptotic functions. Next to the role it plays after translocation to the
nucleus [147–149], loss of AIF from mitochondria may lead toFig. 6.Models of cristae formation and propagation. Several theoretical models for the forma
proposed. The individual steps are shown in chronological sequence from left to right for eac
‘Early-crista junctionmodel’. (C) ‘De-novo vesicle germinationmodel’. (D) ‘Fusion-remnantm
mitochondria is depicted. Other panels in D and E show enlargements of the indicated box.
colors (red/green) for clarity. (F) ‘Cristae ﬁssion–fusion model’. A detailed description of
membrane; M, matrix.disintegration of the mitochondrial inner membrane topology,
favoring bioenergetic impairment and alleviated release of cyto-
chrome c to the cytosol.
Another protein with a recently discovered potential role in
remodeling of the inner membrane is DIC-1, the C. elegans homologue
of the human DICE1 (deleted in cancer 1) [153]. DICE1 seems to
exhibit tumor suppressor function, as its downregulation has been
found in association with non-small cell lung cancer [154], as well as
prostate cancer [155]. The precise function however remains largely
unknown. Han et al. could show that DIC-1 is localized in the
mitochondrial inner membrane, particularly the cristae compartment,
where it plays an essential role in membrane organization. Knock-
down of dic-1 in C. elegans resulted in an extensive remodeling of the
inner membrane, exhibiting an aberrant mitochondrial ultrastructure
with numerous densely packed inner membrane vesicles, and an
increased frequency of apoptosis [153]. The mammalian DICE1 has by
contrast been localized to nuclei [156,157]. It has been implicated in
suppression of cell proliferation [156,158] and small nuclear RNA
processing [159]. Further studies are necessary to address this
apparent discrepancy and will eventually elucidate multiple functions
of the mammalian DICE1.
Although several candidate proteins have been implicated in cristae
remodeling during apoptosis, the physiological relevance of this process
was cast into doubt as, according to computer simulations, CJsmight not
represent an insurmountable diffusion barrier in order to be consistent
with experimental results [116,160]. This view recently found support
by a study which followed mitochondrial transformation during
apoptosis using correlated three-dimensional ﬂuorescence and electron
microscopy [161]. A multi-step transformation of the mitochondrial
inner membrane was observed which temporarily exhibited a number
of isolated vesicular compartments surrounding the matrix and
ultimately resulted in a swollen conformation with very few lamellar
cristae. However, the efﬁcient release of cytochrome c occurred prior to
any of these events [161]. Taken together, the role of cristae remodeling
in apoptosis as well as the respective components and their mode of
action are still under debate.
8.1. Shaping the mitochondrial network is linked to cristae formation
A systematic genome-wide screening in yeast resulted in the
identiﬁcation of novel genes important for mitochondrial distribution
andmorphology (MDM) [162]. One of the identiﬁed proteins, Mdm33p,
was localized to the inner membrane and mitochondria of Mdm33p-
devoid cells show aberrant morphology of their network as well as of
their internal ultrastructure [163]. Mitochondria appear elongated and
along extended stretches only a very narrow matrix space is visible
while at their tips bulky ‘handles’ are formed that contain apparently
normal cristae structures. Overexpression of Mdm33p on the other
hand results in aggregation of mitochondria. Normal cristae are rarely
present, and instead, the inner membrane forms aberrant structures
such as septa and putative vesicles [163]. Mdm33p was hence proposed
to be involved in ﬁssion of the inner mitochondrial membrane.
Mmm1p is an integral protein of the outer membrane of yeast
mitochondria that affects both the overall shape and the ultrastruc-
ture of this organelle [164]. Disruption strains or temperature
sensitive mutants show defective transmission of mtDNA and the
formation of large spherical organelles as well as a dramatic dis-
organization of the mitochondrial cristae compartment, including a
collapse and stack formation of the inner mitochondrial membranetion of cristae (A–E) as well as a model for their propagation from existing cristae (F) are
h model. (A) ‘Invagination model’ or ‘Late-crista junction model’. (B) ‘Balloon model’ or
odel’. (E) ‘Hemifusionmodel’. In the left panel of D an overview of the fusion event of two
The individual leaﬂets of the mitochondrial inner membrane are illustrated in different
all proposed models can be found in the text. IMS, intermembrane space; IM, inner
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the outer mitochondrial membrane, often in close vicinity to mtDNA
nucleoids [165]. Mmm1p was proposed to span the mitochondrial
outer and inner membrane [166], and to connect the mitochondrial
surface to the actin cytoskeleton [167]. Thus, Mmm1pmight be part of
a scaffold-like structure necessary for normal mitochondrial shape
[165]. Recently a new role for the Mmm1-complex (composed of
Mmm1p, Mdm12p, andMdm10p) in the import and assembly of beta-
barrel proteins in the outer membrane was proposed [168,169]. It will
be interesting to dissect the primary role of the Mmm1-complex.
Another interesting candidate protein identiﬁed in the aforemen-
tioned screen for defects in mitochondrial morphology is encoded by
the Mdm38 gene [162]. Its human ortholog, LETM1 (leucine zipper-,
ER-hand-containing transmembrane protein 1), has been associated
with the Wolf–Hirschhorn syndrome (WHS), as it is encoded in the
extended WHS critical region of chromosome 4p, that is often
subjected to microdeletions in WHS patients [170]. Both LETM1 and
its yeast homologue Mdm38p are highly conserved mitochondrial
inner membrane proteins of eukaryotes [171]. Downregulation of the
homologous proteins in yeast, C. elegans andmammalian cells leads to
osmotic swelling of the mitochondrial matrix. These morphological
changes are fully reversible upon administration of the K+/H+-
ionophore nigericin [23,24,172]. Overexpression in contrast results
in condensation of the mitochondrial matrix and cristae swelling
consistent with the suggested role of LETM1/Mdm38p as a K+/H+-
antiporter [172]. The function of LETM1/Mdm38p, however, is still
discussed, as it was also proposed to play a role in the Oxa1 in-
dependent insertion of proteins into the inner membrane with a
critical role in the biogenesis of the respiratory chain [173]. However,
the detailed role of this component in inﬂuencing mitochondrial
ultrastructure is still open.
8.2. Cristae morphology and Parkinson's disease
Mitochondrial dysfunction and oxidative stress are believed to play
key roles in the pathogenesis of Parkinson's disease by promoting
damage to dopaminergic neurons. A number of disease causing genes
has been discovered in familial and sporadic forms of Parkinson's
disease, such as PINK1 (PTEN-induced kinase 1) and parkin [174,175].
PINK1 encodes a serine/threonine kinase localized to the intermem-
brane space [176]. Mutants of pink1 in Drosophila display swollen
mitochondria and fragmented cristae, while overexpression of parkin
rescues this phenotype [19,177]. Furthermore, downregulation of
PINK1 results in depletion of cristae membranes and altered cristae
morphology in human cells [18]. In addition, several recent studies
have indicated a functional association of PINK1 and parkin to the
mitochondrial fusion/ﬁssion machinery [18,178,179]. It has been
shown, that inactivation of the mitochondrial ﬁssion component
Drp1 aggravates the PINK1 as well as the parkinmutant phenotype in
Drosophila, while these mutant phenotypes are suppressed in
situations where mitochondrial ﬁssion is enhanced or the fusion
activity is reduced. Therefore, it was proposed that PINK1 and parkin
act in a pathway promoting mitochondrial ﬁssion [178]. Another
recent study supports this idea and suggests that PINK1 acts through
Fis1 and Drp1 in the regulation of mitochondrial ﬁssion [179]. In
contrast, RNA interference mediated downregulation of PINK1 in
human cells resulted in a fragmentation of the mitochondrial net-
work, which could be rescued by overexpression of wild type but not
pathogenic variants of parkin [18]. Thus, the precise role of PINK1
within the regulation of mitochondrial dynamics remains unclear, as
well as its link to the observed changes in cristae morphology.
9. Determining the architecture of crista junctions
Little is known about the components contributing to the
formation of CJs. One possibility is that CJs are thermodynamicallyfavored structures and thus form spontaneously under certain
conditions [180], as exempliﬁed by their spontaneous reformation in
yeast mitochondria after extensive swelling and recontraction of the
matrix compartment [42]. Alternatively, structural proteins could be
involved in establishing a certain membrane curvature that is crucial
for the architecture of CJs. It has also been speculated that the physical
connection of the outer and inner membranes at the so-called ‘contact
sites’ could play a role in the formation or stabilization of cristae [181].
This idea, however, is lacking experimental support as contact sites
and cristae junctions were reported not to be co-localized [182].
So far, three candidate proteins have been proposed: OPA1,
prohibitin, and mitoﬁlin. The evidence assigning OPA1 an important
role in CJ formation has been described above. The observed effect of
OPA1 overexpression on preventing an increase in CJ diameter upon
induction of apoptosis is probably the most direct evidence in this
direction [123,124]. Prohibitinswere reported to form large oligomeric
ring-like complexes with a diameter ﬁtting well to those reported for
CJs [183]. Thus, it was proposed that the prohibitin complex due to its
physical properties may participate in the formation of CJs [183].
Interestingly, as discussed above, OPA1 processing is controlled by
prohibitins linking these two candidates functionally [129].
John et al. have shown that downregulation of mitoﬁlin led to
ultrastructural disorganization of the mitochondrial inner membrane
and an increased susceptibility to apoptosis [184]. Instead of tubular
cristae, the inner membrane forms closely packed stacks of concentric
sheets while at the same time CJs are not detectable. This points to an
elementary role of mitoﬁlin in organizing cristae and CJs [184]. The
mammalian integral inner membrane protein mitoﬁlin [185,186] is a
very abundant mitochondrial protein [187] that forms homotypic
interactions and is part of a high molecular weight complex [184].
Mass spectrometrical analysis identiﬁed mitoﬁlin as one of the
proteins signiﬁcantly reduced in cortical brain samples of fetal
Down syndrome [188]. In gerbils a base substitution in a conserved
domain of the mitoﬁlin gene correlates with seizure-sensitivity [189].
Upon cold-acclimationmitoﬁlin, together with the F1FO-ATP synthase,
is upregulated in rat brown adipose tissue [190]. Further, mitoﬁlin
seems susceptible to dopamine induced oxidation what makes it a
candidate for inﬂuencing mitochondrial stability in the pathogenesis
of Parkinson's disease [191]. In a recent study, mitoﬁlin has been co-
puriﬁed with six proteins, of which four are known to be implicated in
protein import into mitochondria making the authors propose a role
of mitoﬁlin “in protein import related to maintenance of mitochon-
drial structure” [192]. Future analysis will have to reveal the exact role
of mitoﬁlin in determining cristae morphology.
In spite of all the data accumulated to date on these three
candidate proteins, unfortunately, for none of them a direct role or
speciﬁc localization to CJs has been shown yet. Further work is ne-
cessary to unravel the processes underlying the formation of CJs and to
elucidate the precise molecular mechanisms of OPA1, prohibitin,
mitoﬁlin, and possibly other components involved. This will be es-
pecially challenging, since CJs make up only a very small proportion of
the mitochondrial inner membrane.
10. Theoretical models for the formation and maintenance of
cristae
The mechanism of how cristae and CJs are formed is completely
unknown. Here we formulate several basic models of cristae
formation, which might stimulate further research leading towards
a better understanding of the underlying processes. From an intuitive
perspective one way of cristae formation certainly is that they
originate by invagination of the inner boundary membrane and sub-
sequently CJs are formed (‘Invagination model’ or ‘Late-crista junction
model’) (Fig. 6A). According to Renken et al., bending energy alone
would be sufﬁcient for this spontaneous invagination provided that
the surface of the inner membrane is increasing while the outer
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mediated by a certain local, leaﬂet-speciﬁc lipid composition and/or
certain protein complexes that affect the membrane curvature. The
latter was proposed to occur by means of the oligomerization of F1FO-
ATP synthase [85,106].
Another model in which cristae originate from the IBM is the
‘Balloon model’ or ‘Early-crista junctionmodel’ (Fig. 6B). Here, initially
stable pre-crista junction complexes are formed as ring- or slot-like
structures in the IBM. Such a structure could then serve as an entry
region for the ﬂow of lipids and proteins, thus promoting the for-
mation of new cristae by invagination of the inner membrane along
this guidance. In this model, CJs act as preformed, well deﬁned origins
for the appearance of cristae whereas in the ‘invagination model’ CJs
are formed later after broad infoldings of the inner membrane have
emerged.
An entirely different concept of cristae formation is the origination
of cristae membranes from internal vesicles within the matrix com-
partment that later get connected to the IBM by membrane fusion.
Vesicles within the matrix compartment have indeed been observed
in rare cases such as in mitochondria of patients with a defective
adenine nucleotide carrier [41,193] or after extensive osmotic swelling
and recontraction of the matrix compartment [42]. This raises the
question of how cristae vesicles could be formed in principle. One
possibility is the de novo formation of such vesicles from single
phospholipid molecules (‘De-novo vesicle germination model’) (Fig.
6C). De novo formation of vesicles has been proposed in other
examples such as in the biogenesis of peroxisomes or autophago-
somes [194,195].
The formation of new cristae membranes could also be linked
directly to the fusion of mitochondria. Such a link is supported by the
fact that Mgm1p as well as OPA1 are involved in both processes:
fusion of mitochondria and cristae formation [121–124,126,196]. In
this case, cristae might be regarded as remnants of a preceding fusion
event and would imply that CJs originate at the initial site of inner
membrane fusion (‘Fusion-remnant model’) (Fig. 6D). Initially, (pre)-
CJs would be formed and, concomitant with membrane remodeling,
expand towards the IBM where they eventually become anchored to
the outer membrane. Membrane remodeling is required as the
curvature of the inner membrane has to be inverted during the
transition of an initial fusion region to a tubular or lamellar cristae
structure. Another model involves the formation of a vesicle during
innermembrane fusion, assuming that fusion occurs via a hemifusion-
based mechanism (‘Hemifusion model’) (Fig. 6E). Hemifusion is a
concept of membrane fusion that implies an intermediate state in
which the initially apposed membrane leaﬂets are fused and mixed,
while the distal leaﬂets remain distinct [197,198]. It is currently not
known what happens to the individual leaﬂets of the lipid bilayer
when two mitochondria fuse and whether this follows such a
mechanism. However, the principle of hemifusion is well established
for several types of membrane fusion events, including the cell
invasion by enveloped viruses and vacuolar fusion [199–201]. In the
later case, it was proposed that fusion occurs via a certain type of
hemifusion with the involvement of ‘vertex rings’ resulting in the
formation of luminal vesicles [202]. Nevertheless, as pointed out
above, the formation of a vesicle might be the initial step in cristae
formation.
Both the ‘De-novo vesicle germination model’ and the ‘Hemifu-
sion model’ require that after cristae vesicles are transiently formed
they fuse with the IBM. Topologically, such a fusion event is distinct
from fusion between two mitochondria, as different sides of the
inner membrane are apposed to each other during membrane
docking. There is no experimental evidence so far that fusion of
cristae membranes indeed occurs. However, a dynamic behavior of
cristae membranes was proposed by Mannella and colleagues, as
cristae morphology rapidly changes in a reversible manner depend-
ing on the physiological conditions applied (see above) [42]. Inaddition, evidence for the dynamics of the distribution of proteins
within the inner membrane has been obtained recently [50].
Furthermore, it has to be emphasized that although vesicles have
been observed only rarely in electron micrographs/tomograms one
certainly cannot neglect this possibility. Such vesicles are eventually
only formed transiently with a life-time that is very short in contrast
to the life-time of cristae structures, thus being barely available for
direct observations by current means. The concept of fusion and also
of ﬁssion of cristae membranes is intriguing as this would also
provide a possibility for the propagation, in contrast or in addition to
the de novo formation of cristae membranes. Propagation of cristae
could be mediated such that cristae vesicles bud off from preexisting
cristae and re-fuse with the inner membrane at a different site
within the mitochondrion (‘Cristae ﬁssion–fusion model’) (Fig. 6F).
This would have fundamental consequences on the dynamic
behavior of lipids and proteins in the inner membrane as well as
of soluble components of the intermembrane space. Furthermore,
this would imply that oxidative phosphorylation might be regulated
in a novel way; maybe cristae-‘vesicles’ have to be considered in a
certain sense as a transient pendant to the thylakoids of chloroplasts.
It is obvious that the generation and exploitation of the electro-
chemical gradient across the inner membrane within a vesicle is
entirely different to the situation when the intracristal space is part
of the same aqueous compartment as the cytosol (as the outer
membrane is considered to be permeable to small solutes). In this
regard, studying cristae dynamics is likely to be of high relevance to
bioenergetic aspects of mitochondrial physiology. This is technically
difﬁcult as studying cristae dynamics in mitochondria by static
techniques such as electron microscopy is not possible. Thus, it will
be one of the great future challenges to further develop high-
resolution imaging techniques allowing to analyze such putative
dynamic processes in real-time.
Taken together, the proposed set of potential models provides a
theoretical framework for the understanding of cristae formation and
propagation. The mentioned models are not mutually exclusive and
presumably not complete either. Still, we consider it as important to
speculate about such models of cristae formation in order to derive
testable hypotheses. It certainly will help to broaden our under-
standing for the factors and mechanisms that govern the huge
variability of mitochondrial ultrastructures and how they are linked to
mitochondrial bioenergetics.
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